Patients (n = 327) with community-acquired pneumonia were randomised and treated with study drug; 160 received clarithromycin and 167 received amoxicillin/clavulanic ...

The clinical cure rate was significantly lower in the amoxicillin-clavulanate group than in the ciprofloxacin group (58% vs. 77%), regardless of whether the pathogens were susceptible or resistant ...

PHOP, as a research area, evaluates the cost, access, and quality of pharmaceutical care from clinical, sociobehavioral, economic, organizational, and technological perspectives. Traditional and ...

NASA’s Parker Solar Probe skimmed the sun on Christmas Eve and lived to tell the tale. The heat-hardened spacecraft made its closest solar flyby yet at 6:53 a.m. EST on December 24. It came ...

Rising healthcare consumerization, self-care and cost-containment have opened new opportunities for private equity in pharma, along with large companies in the sector increasingly pursuing post ...

The deal between Alibaba and Chinese private-equity firm DCP Capital was reached on the last day of 2024, involving the disposal of the Hangzhou-based company’s interest in Sun Art at HK$1.75 ...

In the new year, the Indian pharmaceutical sector will have to grapple with new realities, at home and overseas. On home ground, the updated Uniform Code for Pharmaceutical Marketing Practices ...

SINGAPORE – Home-grown singer Stefanie Sun has admitted to feeling some pressure while preparing for her upcoming world tour, Aut Nihilo Sun Yanzi In Concert. “I am welcoming 2025 with wide ...

Mumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Zaza Industrial Holdings K.K, Japan, under which Sun Pharma has agreed to sell 100% shares held in Sun Pharma Japan ...

Sun Pharmaceutical Industries share price gained in the early trade on January 1 after the company is going to sell its entire holding in Japanese subsidiary. At 09:26am, Sun Pharmaceutical ...

Sun Pharma stated that it has entered into an agreement with Zaza Industrial Holdings K.K., Japan, to sell 100% of its shares in Sun Pharma Japan Technical Operations, a step-down subsidiary.